Stone X Group Inc. Bio Restorative Therapies, Inc. Transaction History
Stone X Group Inc.
- $915 Million
- Q1 2024
A detailed history of Stone X Group Inc. transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 34,850 shares of BRTX stock, worth $73,882. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,850Holding current value
$73,882% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding BRTX
# of Institutions
14Shares Held
385KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ169KShares$357,3137.93% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$85,7680.0% of portfolio
-
Wealth Alliance Mellville, NY40KShares$84,8000.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny24.9KShares$52,7050.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$43,4000.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $7.74M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...